Benchmarking and Laboratory Indicator Program: a valuable ally in the pandemic

P

The role of the tool during the health crisis was the theme at the 1st Virtual Congress of SBPC/ML.

Test, test, test. That was the recommendation of the World Health Organization (WHO) to countries in March 2020 to fight the new coronavirus. Laboratories were challenged – amid changes in routines, adaptations of teams and care for their staff – to quickly introduce detection for SARS-CoV2, without neglecting the demand for tests to control other existing diseases.

Faced with the unquestionable need to provide reliable reports at that time, managers needed to protect the reputation of their institutions and not allow quality to be impacted by the changes resulting from the Covid-19 pandemic.

How to ensure continuity of processes, meet the needs of patients, care for employees and avoid significant losses in the organization’s cash? To assist in these responses, the measurement and knowledge of the weaknesses and strengths of the laboratory are determining factors for decisions.

The role of the Benchmarking and Laboratory Indicator Program (PBIL) at this time of health crisis was one of the subjects discussed at the 1st Virtual Congress of the Brazilian Society of Clinical Pathology and Laboratory Medicine (SBPC/ML), which took place between September 25 and October 2.

PBIL, created in 2006 in an association between Controllab and SBPC/ML, is a management tool that quantifies the laboratory’s performance and compares it with the market. Its scope was increased in 2016 – today there are about 150 indicators – and it received adjustments that allowed the comparison of data also internationally.

pbil aliado2

Organized processes are even more important in times of crisis, says Dr. Larissa Welter, technical director at Hemos Laboratório Médico, in Blumenau (SC), one of the PBIL participants. “Management with indicators contributes precisely to conscious decision making. When you know your data, you are not ‘myopic’. And he still manages to verify the effectiveness of the decisions it took when compared to the market“, she argues, who saw seven of the 10 units of her laboratory close in Santa Catarina overnight due to restrictive circulation measures in the city, which also affected private laboratories such as Hemos.

The challenges that arose in March required quick action. The priorities started to be to ensure the company’s cashier , ensure the safety and health of employees and maintain the operation for customers. “Everything was done in a short space of time and needed to be conducted in an innovative way”. The laboratory focused on environmental safety, valuing professionals, prudently resuming strategic actions and controlling expenses to avoid waste. “It is not a game of chance: organized processes, with adequate information, provide agility in decisions”. In her presentation at the virtual congress, Dr. Larissa Welter showed that investment in Benchmarking over time was essential for the organization’s strategies in the face of the need for quick and effective actions.

Knowing the processes and how competitive they are compared to other organizations is not just a survival requirement for private institutions, since quality and growth are necessary attributes for public organizations as well. With the authority of those who are in charge of the Quality Center of the Central Laboratory Division of the Hospital das Clínicas of the USP Medical School, a reference in serving Covid-19 in São Paulo, Dr. Maria Elizabete Mendes presented the institution’s indicators virtual congress, highlighting that laboratory performance is crucial to provide patients with safe, effective and efficient care. “Benchmarking is a precious tool, especially in times of pandemic”, she concluded.

pbil aliado3

Not all laboratories participating in the PBIL were able to report their data to obtain Benchmarking, precisely in a fundamental period of evaluation of the effectiveness of emergency strategies. Luiza Bottino, from Controllab’s Service Management, noted a drop in the responses of about 15% in the first months of the pandemic. Having reduced staff during this period may have impacted the process. The task, however, can become much simpler when some steps are automated – such as standardized data collection.

Since 2018, Controllab has been working intensively with companies that develop laboratory information systems (LIS) to integrate their clients’ management software into the indicator program. When the laboratory system is integrated with PBIL, data is automatically transmitted to the Controllab tool. “Certainly, it is a facilitator for managers because it frees up this labor that is busy with manual collection to be used in another more effective task for the process: the critical analysis of the data generated by the program”.

Controllab has already approved the integration of PBIL with three developers of laboratory systems – Karyon, Pixeon and Confidentia, that last one from Portugal. More recently, Matrix has also started a partnership with the company. “They are more than partner companies”, points out Luiza. “The developers are also contributing to improvements in the programs. And we are moving towards integrating more companies ”.

Before the pandemic, recalls Luiza, the scenario was already challenging for laboratories: a competitive market, with a client that increasingly demands quality, speed in delivery and efficiency of results. When the crisis came, the relevance of the diagnosis was even more evident. “Before, making a decision without concrete data was difficult. With the pandemic, this got worse, it became a threat to the survival of the laboratory”.

More information about PBIL and other Controllab solutions can be found on the website, by e-mail contato@controllab.com or by phone and WhatsApp +55 (21) 97901-0310 and +55 (21) 98036-1592.

Sign up for our newsletter

Receive relevant publications about labs, solutions for quality
management and optimization of business management.

LOG IN

acesso ao sitema

Estamos enfrentando alguns problemas de acesso ao sistema, pedimos a compreensão de todos. Tente novamente em alguns minutos.

COOKIES NOTICE

We use cookies and other similar technologies to improve your experience, enabling a more personalized navigation, according to the characteristics and your interest.

For more information see our Privacy and Security Policy.

PRM 0009

Accreditation Cgcre/Inmetro - Certified Reference Material Producer

Controllab has been accredited as a Certified Reference Material Producer (MRC) since 2016 by Inmetro’s General Coordination for Accreditation (CGCRE), under the PMR 0009 number. The assessment of this conformity is carried out according to the requirements established in ABNT NBR standards ISO 17034 and Inmetro, thus ensuring competence for the production of MRCs, according to the Scope of Accreditation.

CAL 0214

Accreditation Cgcre/Inmetro - Calibration Laboratory

In December 2002, the Calibration Laboratory was accredited by Inmetro’s General Coordination for Accreditation (CGCRE). With this recognition, it became an integral part of the Brazilian network of accredited laboratories, under nº214. Since then, it is periodically evaluated for the maintenance and/or extension of accreditation.

PEP 0003

Accreditation Cgcre/Inmetro - Control Laboratory

In September 2011, Controllab was accredited by Inmetro’s General Coordination for Accreditation (CGCRE) as a proficiency test provider, under nº PEP0003. Initially as part of a pilot project by Inmetro, this accreditation was based on ILAC G13: 2007 and included several clinical and hemotherapy tests. In the periodic evaluations of this accreditation, new segments and tests are included and the evaluation is now conducted according to ABNT NBR ISO/IEC 17043.

This accreditation attests to Controllab’s technical competence to develop and conduct proficiency tests in accordance with international requirements and enables it to be recognized in other countries, in accordance with mutual recognition agreements signed by Brazil in Mercosur, the Americas and Europe.